Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

  • LW Seymour
  • , DR Ferry
  • , DJ Kerr
  • , Daniel Rea
  • , M Whitlock
  • , R Poyner
  • , C Boivin
  • , S Hesslewood
  • , C Twelves
  • , R Blackie
  • , A Schatzlein
  • , D Jodrell
  • , D Bissett
  • , H Calvert
  • , M Lind
  • , A Robbins
  • , S Burtles
  • , R Duncan
  • , J Cassidy

Research output: Contribution to journal › Article › peer-review

218 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science